In vivo effects of nonoxynol-9 on endometrial immune cell populations.
Rahangdale
Lisa
L
Greenblatt
Ruth M
RM
Perry
Jean
J
Darragh
Teresa M
TM
Kobayashi
Akiko
A
Smith-McCune
Karen K
KK
D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002584:Cervix Uteri / Q000187:drug effects / Q000276:immunology; D004716:Endometritis / Q000139:chemically induced* / Q000276:immunology; D004717:Endometrium / Q000187:drug effects* / Q000276:immunology; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D017137:Nonoxynol / Q000008:administration & dosage / Q000009:adverse effects*; D010865:Pilot Projects; D013089:Spermatocidal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D002575:Uterine Cervicitis / Q000139:chemically induced / Q000276:immunology; D055815:Young Adult
D013089:Spermatocidal Agents; D013501:Surface-Active Agents; D017137:Nonoxynol
Cancer Res. 2004 Sep 15;64(18):6766-74
15374995
Hum Reprod. 2001 Jun;16(6):1151-4
11387285
Mucosal Immunol. 2008 Sep;1(5):412-20
19079205
Lancet Infect Dis. 2008 Nov;8(11):685-97
18992405
Lancet. 2002 Sep 28;360(9338):971-7
12383665